Alba Luengo

5.3k total citations · 3 hit papers
15 papers, 2.5k citations indexed

About

Alba Luengo is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Alba Luengo has authored 15 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Alba Luengo's work include Cancer, Hypoxia, and Metabolism (9 papers), Metabolism, Diabetes, and Cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Alba Luengo is often cited by papers focused on Cancer, Hypoxia, and Metabolism (9 papers), Metabolism, Diabetes, and Cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Alba Luengo collaborates with scholars based in United States, Spain and Austria. Alba Luengo's co-authors include Matthew G. Vander Heiden, Dan Y. Gui, Lucas B. Sullivan, Caroline A. Lewis, Craig J. Thomas, Aaron M. Hosios, Clary B. Clish, Tyler Jacks, Allison N. Lau and Shawn M. Davidson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Genes & Development.

In The Last Decade

Alba Luengo

15 papers receiving 2.5k citations

Hit Papers

Targeting Metabolism for Cancer Therapy 2016 2026 2019 2022 2017 2016 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alba Luengo United States 11 1.8k 1.4k 396 197 189 15 2.5k
Hubert Lincet France 24 1.6k 0.9× 1.1k 0.8× 461 1.2× 110 0.6× 170 0.9× 35 2.3k
Andrew R. Mullen United States 13 2.1k 1.1× 1.7k 1.2× 252 0.6× 212 1.1× 251 1.3× 15 2.8k
Wenjing Du China 20 1.8k 1.0× 1.3k 0.9× 623 1.6× 209 1.1× 109 0.6× 36 2.7k
Ashley Solmonson United States 12 1.8k 1.0× 1.3k 0.9× 424 1.1× 233 1.2× 225 1.2× 18 2.8k
Kelly M. Kennedy United States 7 1.6k 0.9× 1.6k 1.1× 359 0.9× 192 1.0× 108 0.6× 7 2.3k
Dimitrios Anastasiou United Kingdom 15 1.7k 1.0× 981 0.7× 384 1.0× 254 1.3× 158 0.8× 30 2.5k
Jaekyoung Son South Korea 20 1.6k 0.9× 1.3k 0.9× 643 1.6× 111 0.6× 208 1.1× 31 2.4k
Krushna C. Patra United States 14 1.9k 1.0× 1.5k 1.0× 527 1.3× 161 0.8× 84 0.4× 18 2.8k
Yekaterina Y. Zaytseva United States 24 1.4k 0.8× 1.0k 0.7× 368 0.9× 93 0.5× 120 0.6× 49 2.1k
Evan C. Lien United States 17 1.4k 0.7× 777 0.5× 393 1.0× 178 0.9× 123 0.7× 28 2.0k

Countries citing papers authored by Alba Luengo

Since Specialization
Citations

This map shows the geographic impact of Alba Luengo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alba Luengo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alba Luengo more than expected).

Fields of papers citing papers by Alba Luengo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alba Luengo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alba Luengo. The network helps show where Alba Luengo may publish in the future.

Co-authorship network of co-authors of Alba Luengo

This figure shows the co-authorship network connecting the top 25 collaborators of Alba Luengo. A scholar is included among the top collaborators of Alba Luengo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alba Luengo. Alba Luengo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Luengo, Alba, Zhaoqi Li, Dan Y. Gui, et al.. (2020). Increased demand for NAD+ relative to ATP drives aerobic glycolysis. Molecular Cell. 81(4). 691–707.e6. 351 indexed citations breakdown →
2.
Chatterjee, Nimrat, Matthew A. Whitman, Cynthia Harris, et al.. (2020). REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks. Proceedings of the National Academy of Sciences. 117(46). 28918–28921. 32 indexed citations
3.
Dalin, Simona, Mark R. Sullivan, Allison N. Lau, et al.. (2019). Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance. Cancer Research. 79(22). 5723–5733. 93 indexed citations
4.
Luengo, Alba, Keene L. Abbott, Shawn M. Davidson, et al.. (2019). Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer. Nature Communications. 10(1). 5604–5604. 53 indexed citations
5.
Grahovac, Jelena, Shiwei Han, Hao Liu, et al.. (2019). Abstract B06: The angiotensin receptor blocker and partial PPARγ agonist telmisartan inhibits the growth of pancreatic ductal adenocarcinoma. Cancer Research. 79(24_Supplement). B06–B06. 1 indexed citations
6.
Alkan, H. Furkan, Alba Luengo, Corina T. Madreiter‐Sokolowski, et al.. (2018). Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting. Cell Metabolism. 28(5). 706–720.e6. 131 indexed citations
7.
Sullivan, Lucas B., Alba Luengo, Laura V. Danai, et al.. (2018). Aspartate is an endogenous metabolic limitation for tumour growth. Nature Cell Biology. 20(7). 782–788. 243 indexed citations
8.
Luengo, Alba, Dan Y. Gui, & Matthew G. Vander Heiden. (2017). Targeting Metabolism for Cancer Therapy. Cell chemical biology. 24(9). 1161–1180. 666 indexed citations breakdown →
9.
Papagiannakopoulos, Thales, Benjamin A. Olenchock, Julia E. Heyman, et al.. (2016). Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer. Cell Metabolism. 23(3). 517–528. 554 indexed citations breakdown →
10.
Dayton, Talya L., Vasilena Gocheva, Kathryn Miller, et al.. (2016). Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma. Genes & Development. 30(9). 1020–1033. 120 indexed citations
11.
Gui, Dan Y., Lucas B. Sullivan, Alba Luengo, et al.. (2016). Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin. Cell Metabolism. 24(5). 716–727. 224 indexed citations
12.
Dayton, Talya L., Vasilena Gocheva, Kathryn Miller, et al.. (2016). Abstract PR04: Germline loss of PK-M2 promotes metabolic syndrome and hepatocellular carcinoma. Molecular Cancer Research. 14(4_Supplement). PR04–PR04. 3 indexed citations
13.
Gunja, Najmuddin J., et al.. (2011). Migration responses of outer and inner meniscus cells to applied direct current electric fields. Journal of Orthopaedic Research®. 30(1). 103–111. 18 indexed citations
14.
Luengo, Alba, et al.. (2011). Índice de masa corporal y aumento de peso en el embarazo. Resultado obstétrico de la inducción de parto. Clínica e Investigación en Ginecología y Obstetricia. 39(5). 199–202. 2 indexed citations
15.
Luengo, Alba, et al.. (2009). Embarazo ectópico gemelar bicorial espontáneo. Diagnóstico ecográfico transvaginal. Clínica e Investigación en Ginecología y Obstetricia. 37(5). 211–213. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026